Loading clinical trials...
Loading clinical trials...
Hypotension Prediction Index Guided Prevention of Intradialytic Hypotension During Intermittent Renal Replacement Therapy in Intensive Care Units
This single-center, crossover randomized controlled trial (HyPIR-ICU) investigates whether a Hypotension Prediction Index (HPI)-guided management strategy can reduce intradialytic hypotension (IDH) during prolonged intermittent renal replacement therapy (PIRRT) in critically ill patients. All participants must have an indwelling arterial catheter for continuous hemodynamic monitoring.
This study explores whether HPI-guided management during PIRRT can randomization: Block randomization stratified by kidney status (AKI vs. ESKD) and vasopressor use. All parameters are monitored in real-time via the HemosphereⓇ system and reassessed after each intervention.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Division of Nephrology, Faculty of Medicine, Chulalongkorn University
Bangkok, Thailand
Start Date
October 10, 2025
Primary Completion Date
January 31, 2026
Completion Date
December 31, 2026
Last Updated
November 17, 2025
46
ESTIMATED participants
Hypotensive prediction index
DEVICE
Standard of care monitoring
DEVICE
Lead Sponsor
Chulalongkorn University
NCT04163614
NCT05936710
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07033260